Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Basolateral Nuclear Complex | 5 | 2022 | 28 | 2.430 |
Why?
|
| Receptors, Kainic Acid | 6 | 2013 | 24 | 2.060 |
Why?
|
| Hippocampus | 8 | 2016 | 471 | 1.450 |
Why?
|
| Receptor, Muscarinic M1 | 2 | 2021 | 17 | 1.410 |
Why?
|
| Neurons | 6 | 2021 | 881 | 1.210 |
Why?
|
| Anticonvulsants | 3 | 2013 | 223 | 1.160 |
Why?
|
| Receptors, GABA-A | 4 | 2019 | 89 | 1.100 |
Why?
|
| Synaptic Transmission | 8 | 2022 | 236 | 1.040 |
Why?
|
| Dioxolanes | 2 | 2013 | 8 | 0.880 |
Why?
|
| Status Epilepticus | 3 | 2013 | 74 | 0.870 |
Why?
|
| Neural Inhibition | 4 | 2011 | 80 | 0.860 |
Why?
|
| Acetylcholine | 1 | 2022 | 64 | 0.840 |
Why?
|
| Protein Subunits | 6 | 2013 | 99 | 0.800 |
Why?
|
| Synapses | 4 | 2019 | 222 | 0.780 |
Why?
|
| Membrane Proteins | 3 | 2013 | 617 | 0.700 |
Why?
|
| Vesicular Glutamate Transport Protein 1 | 1 | 2019 | 3 | 0.680 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2019 | 4 | 0.680 |
Why?
|
| Zinc | 2 | 2011 | 73 | 0.660 |
Why?
|
| Dendrites | 3 | 2017 | 44 | 0.650 |
Why?
|
| Amygdala | 2 | 2019 | 159 | 0.630 |
Why?
|
| Animals | 25 | 2022 | 20881 | 0.610 |
Why?
|
| Interneurons | 3 | 2017 | 70 | 0.610 |
Why?
|
| Drug Synergism | 3 | 2013 | 260 | 0.590 |
Why?
|
| Receptors, Muscarinic | 2 | 2022 | 44 | 0.570 |
Why?
|
| Epilepsy | 2 | 2013 | 336 | 0.570 |
Why?
|
| Protein Multimerization | 2 | 2013 | 71 | 0.520 |
Why?
|
| Rats | 14 | 2016 | 5300 | 0.520 |
Why?
|
| Benzodiazepines | 2 | 2013 | 130 | 0.510 |
Why?
|
| Membrane Potentials | 2 | 2012 | 200 | 0.490 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2015 | 266 | 0.470 |
Why?
|
| Learning | 1 | 2016 | 186 | 0.460 |
Why?
|
| Neural Pathways | 1 | 2016 | 324 | 0.460 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2017 | 2083 | 0.450 |
Why?
|
| Oocytes | 2 | 2010 | 57 | 0.430 |
Why?
|
| Ion Channel Gating | 1 | 2012 | 42 | 0.420 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 649 | 0.390 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2019 | 208 | 0.360 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2008 | 87 | 0.360 |
Why?
|
| Memory | 1 | 2011 | 214 | 0.330 |
Why?
|
| Calcium | 1 | 2012 | 929 | 0.310 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2008 | 4 | 0.310 |
Why?
|
| Neuregulins | 1 | 2008 | 11 | 0.310 |
Why?
|
| Presynaptic Terminals | 2 | 2019 | 34 | 0.300 |
Why?
|
| Neuronal Plasticity | 4 | 2015 | 274 | 0.300 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2004 | 75 | 0.290 |
Why?
|
| Receptor, Muscarinic M2 | 2 | 2017 | 8 | 0.280 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 2550 | 0.260 |
Why?
|
| Male | 14 | 2022 | 37321 | 0.260 |
Why?
|
| Long-Term Potentiation | 3 | 2010 | 53 | 0.250 |
Why?
|
| Aging | 1 | 2011 | 911 | 0.240 |
Why?
|
| Dentate Gyrus | 1 | 2004 | 13 | 0.240 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 38 | 0.240 |
Why?
|
| Glutamic Acid | 3 | 2013 | 332 | 0.240 |
Why?
|
| Xenopus | 3 | 2010 | 30 | 0.220 |
Why?
|
| Mice | 5 | 2022 | 8474 | 0.220 |
Why?
|
| HEK293 Cells | 3 | 2013 | 326 | 0.220 |
Why?
|
| Receptors, Cholinergic | 1 | 2022 | 30 | 0.220 |
Why?
|
| Cholinergic Agents | 1 | 2022 | 12 | 0.220 |
Why?
|
| Protons | 1 | 2003 | 57 | 0.210 |
Why?
|
| Polyamines | 1 | 2003 | 79 | 0.210 |
Why?
|
| Patch-Clamp Techniques | 3 | 2009 | 204 | 0.210 |
Why?
|
| Thalamus | 1 | 2022 | 82 | 0.210 |
Why?
|
| Macaca mulatta | 1 | 2021 | 77 | 0.190 |
Why?
|
| Leptin | 2 | 2011 | 80 | 0.180 |
Why?
|
| Diazepam | 1 | 2019 | 23 | 0.170 |
Why?
|
| Inhibitory Postsynaptic Potentials | 3 | 2017 | 25 | 0.170 |
Why?
|
| Dendritic Spines | 1 | 2019 | 76 | 0.160 |
Why?
|
| Receptor, Insulin | 2 | 2015 | 71 | 0.150 |
Why?
|
| Cholinergic Neurons | 1 | 2016 | 5 | 0.130 |
Why?
|
| Axons | 1 | 2017 | 139 | 0.130 |
Why?
|
| Neuroanatomy | 1 | 2016 | 14 | 0.130 |
Why?
|
| Spatial Learning | 1 | 2015 | 12 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 618 | 0.120 |
Why?
|
| Receptors, GABA | 1 | 2013 | 8 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2015 | 241 | 0.110 |
Why?
|
| Obesity | 2 | 2011 | 1076 | 0.110 |
Why?
|
| Female | 3 | 2022 | 38074 | 0.110 |
Why?
|
| Lignans | 1 | 2012 | 10 | 0.100 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 15 | 0.100 |
Why?
|
| GABA Agents | 1 | 2012 | 18 | 0.100 |
Why?
|
| Action Potentials | 1 | 2013 | 223 | 0.100 |
Why?
|
| Kynurenic Acid | 1 | 2011 | 26 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 420 | 0.100 |
Why?
|
| Humans | 7 | 2016 | 68618 | 0.100 |
Why?
|
| Biphenyl Compounds | 1 | 2012 | 184 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 11 | 0.100 |
Why?
|
| Rats, Inbred F344 | 1 | 2011 | 104 | 0.090 |
Why?
|
| Food Deprivation | 1 | 2010 | 22 | 0.090 |
Why?
|
| Pilocarpine | 1 | 2010 | 9 | 0.090 |
Why?
|
| Conditioning, Classical | 1 | 2011 | 57 | 0.090 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2010 | 21 | 0.090 |
Why?
|
| Biological Transport | 1 | 2011 | 210 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2010 | 765 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 248 | 0.090 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2008 | 59 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 81 | 0.090 |
Why?
|
| Protein Binding | 1 | 2013 | 1027 | 0.090 |
Why?
|
| Xenopus laevis | 1 | 2009 | 60 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 329 | 0.080 |
Why?
|
| Markov Chains | 1 | 2009 | 133 | 0.080 |
Why?
|
| Bicuculline | 1 | 2008 | 17 | 0.080 |
Why?
|
| Binding Sites | 1 | 2009 | 631 | 0.080 |
Why?
|
| Pyramidal Cells | 2 | 2019 | 79 | 0.080 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 59 | 0.080 |
Why?
|
| Chelating Agents | 1 | 2008 | 47 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 166 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2011 | 597 | 0.070 |
Why?
|
| Potassium | 1 | 2008 | 168 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 415 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2008 | 396 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1293 | 0.070 |
Why?
|
| Xanthenes | 1 | 2004 | 18 | 0.060 |
Why?
|
| Perforant Pathway | 1 | 2004 | 4 | 0.060 |
Why?
|
| Amino Acids | 1 | 2004 | 131 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2003 | 49 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2003 | 107 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2003 | 87 | 0.050 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 99 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 1047 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 742 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2015 | 1200 | 0.040 |
Why?
|
| Synaptic Potentials | 1 | 2019 | 8 | 0.040 |
Why?
|
| Brain | 1 | 2010 | 2176 | 0.040 |
Why?
|
| Cell Line | 1 | 2003 | 1752 | 0.040 |
Why?
|
| Mutation | 1 | 2003 | 1213 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2673 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 44 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 62 | 0.040 |
Why?
|
| Parvalbumins | 1 | 2017 | 29 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2017 | 525 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2791 | 0.030 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2011 | 10 | 0.020 |
Why?
|
| Electroshock | 1 | 2011 | 36 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2010 | 25 | 0.020 |
Why?
|
| Autoradiography | 1 | 2010 | 94 | 0.020 |
Why?
|
| Corticosterone | 1 | 2010 | 51 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 114 | 0.020 |
Why?
|
| Serine | 1 | 2010 | 99 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2010 | 78 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 238 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 88 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 447 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 554 | 0.020 |
Why?
|
| Insulin | 1 | 2010 | 619 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2004 | 1692 | 0.010 |
Why?
|